As of Sep 19
| +0.74 / +0.87%|
The 28 analysts offering 12-month price forecasts for Novartis have a median target of 88.81, with a high estimate of 100.76 and a low estimate of 75.42. The median estimate represents a +3.44% increase from the last price of 85.85.
The current consensus among 32 polled investment analysts is to Hold stock in Novartis. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.